Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium- 99m-hydroxymethylenediphosphate negative bone tumors

M. Sasaki, Y. Ichiya, Y. Kuwabara, M. Otsuka, T. Fukumura, Y. Kawai, H. Koga, K. Masuda

研究成果: Contribution to journalArticle査読

18 被引用数 (Scopus)

抄録

We have encountered two cases of bone tumors with high 18F- fluorodeoxyglucose (FDG) uptake and negative 99mTc-HMDP bone scintigraphy, including a patient with myeloma and a patient with a metastatic bone tumor from esophageal cancer. Bone scintigraphy with a 99mTc-phosphate complex reflects osteoblastic activity in the bone tissue surrounding the tumor, whereas the accumulation of FDG is associated with the metabolic activity of the tumor itself. An FDG-PET study can therefore be used as a complementary study for the detection and follow-up of bone tumors when a 99mTc- phosphate bone scintigram is negative.

本文言語英語
ページ(範囲)288-290
ページ数3
ジャーナルJournal of Nuclear Medicine
34
2
出版ステータス出版済み - 1 1 1993

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

フィンガープリント 「Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium- 99m-hydroxymethylenediphosphate negative bone tumors」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル